Aortic Stenosis Hyalectan Remodeling Revealed by Proteomics and Glycoproteomics
Arteriosclerosis, Thrombosis, and Vascular Biology · 2026
DOI: 10.1161/atvbaha.126.323867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Siqi Yin und 22 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Faculty of Medicine, Imperial College London, United Kingdom (S.Y., U.M., J.B.-B., E.D., X.Y., P.S., B.S., N.L., M…. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Proteomics, Aortic Valve, Calcinosis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
BACKGROUND: Calcific aortic valve (AV) disease (CAVD) is recognized as an active pathological process involving extracellular matrix remodeling. This study investigates extracellular matrix remodeling through proteomic analysis and a novel mouse model of aortic stenosis. METHODS: Proteomic and glycoproteomic analyses were conducted on AV leaflets from heart transplant donors (n=29) and patients with CAVD (n=17). Each CAVD sample was subdivided into noncalcified and calcified regions. To investigate the functional impact of extracellular matrix remodeling on aortic stenosis, we crossed apolipoprotein E-deficient mice ( ApoE −/− ) with mice lacking the catalytic domain of ADAMTS5 ( Adamts5 Δcat ) to generate a mouse model combining hyalectan accumulation with hypercholesterolemia. RESULTS: Proteomic and glycoproteomic analyses revealed hyalectan accumulation in CAVD compared with control valves. Versican predominated in noncalcified regions, while aggrecan was enriched in calcified regions. The shift in hyalectan composition correlated with changes in AV pressure gradient, elevated osteoblast-like cell markers, and inflammatory proteins, most notably pentraxin 3. Both versican and aggrecan are characterized by their ability to bind hyaluronan and serve as substrates of ADAMTS5. In Adamts5 Δcat /ApoE − /− mice, hyalectan accumulation was associated with narrowed aortic cusp separation and increased post-AV velocity. Proteomic analysis of AVs from Adamts5 Δcat /ApoE − /− mice revealed elevated versican, aggrecan, and pentraxin 3, recapitulating key features of human CAVD. Single-cell RNA sequencing and in vitro experiments linked versican to activated valve interstitial cells, while aggrecan colocalized with calcification markers in osteoblast-like cells. Pentraxin 3 was bound to hyaluronan and accumulated in calcified AVs. ADAMTS5 deficiency was sufficient to cause intact versican accumulation and promote valve interstitial cell activation, accompanied by increased expression of osteopontin. Osteopontin is a ligand of CD44, a principle hyaluronan receptor. CONCLUSIONS: This study highlights hyaluronan remodeling during aortic stenosis pathogenesis. A shift from versican to aggrecan in human CAVD correlates with changes in AV pressure gradient. In Adamts5 Δcat /ApoE − /− mice, impaired hyalectan catabolism promotes aortic stenosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Heart and Lung Institute, Faculty of Medicine, Imperial College London, United Kingdom (S.Y., U.M., J.B.-B., E.D., X.Y., P.S., B.S., N.L., M.M.).
- British Heart Foundation Centre for Cardiovascular Science, College of Medicine and Veterinary Medicine, University of Edinburgh, United Kingdom (A.K.B., R.B., M.R.D.).
- Centre for Inflammation Research, Institute for Regeneration and Repair, College of Medicine and Veterinary Medicine, University of Edinburgh, United Kingdom (D.M., N.C.H.).
- Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan (W.-Y.L.).
- School of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, British Heart Foundation Centre, London, United Kingdom (M.F., F.B., A.M.S., K.T.).
- Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria (L.E.S., C.H., M.M.).
ORCID-Profile: Javier Barallobre-Barreiro, Anna K Barton, Dyana Markose, Xiaoke Yin, Padmini Sarathchandra, Bhawana Singh, Wen-Yu Lin, Marika Fava, Lukas E Schmidt, Ajay M Shah, Konstantinos Theofilatos, Najma Latif, Christian Hengstenberg, Béla Merkely, Neil C Henderson, Marc R Dweck, Manuel Mayr
Förderung
- Wellcome Trust
Zitieren
APA
Yin, S., Mayr, U., Barallobre-Barreiro, J., Duregotti, E., Barton, A. K., Bing, R., Markose, D., Yin, X., Sarathchandra, P., Singh, B., Lin, W. Y., Fava, M., Schmidt, L. E., Baig, F., Shah, A. M., Theofilatos, K., Latif, N., Hengstenberg, C., Radovits, T., …, & Mayr, M. (2026). Aortic Stenosis Hyalectan Remodeling Revealed by Proteomics and Glycoproteomics. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.126.323867
Vancouver
Yin S, Mayr U, Barallobre-Barreiro J, Duregotti E, Barton AK, Bing R, et al. Aortic Stenosis Hyalectan Remodeling Revealed by Proteomics and Glycoproteomics. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.126.323867
BibTeX
@article{Yin2026,
author = {Yin, Siqi and Mayr, Ursula and Barallobre-Barreiro, Javier and Duregotti, Elisa and Barton, Anna K and Bing, Rong and Markose, Dyana and Yin, Xiaoke and Sarathchandra, Padmini and Singh, Bhawana and Lin, Wen-Yu and Fava, Marika and Schmidt, Lukas E and Baig, Ferheen and Shah, Ajay M and Theofilatos, Konstantinos and Latif, Najma and Hengstenberg, Christian and Radovits, Tamás and Merkely, Béla and Henderson, Neil C and Dweck, Marc R and Mayr, Manuel},
title = {Aortic Stenosis Hyalectan Remodeling Revealed by Proteomics and Glycoproteomics},
journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
year = {2026},
doi = {10.1161/atvbaha.126.323867}
}
EUVIMED